- Brand Name: Kesimpta® (kes·imp·ta)
- Chemical Name: Ofatumumab (oh-fah-TOO-moo-mab)
- Usage in MS: Disease-Modifying Agent
- Generic Available: No
This medication is taken by injection.
Description
Kesimpta® is a monoclonal antibody that binds to a docking site (CD20) on some immune B cells and depletes them. B cells are among immune cells that have been implicated in causing nervous system damage in MS. Kesimpta is approved by the FDA for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease, in adults.
Read the Society's news bulletin on the FDA approval of ofatumumab
here.
Click
here to see the prescribing information for healthcare professionals.
Click
here to see the medication guide for patients.
Support
kesimpta.com
1-855-KESIMPTA (1-855-537-4678)
Financial Assistance Program
Alongside™ KESIMPTA®
1-855-537-4678
kesimpta.com/patient-support/financial-resources